Annotation Detail for HNRNPR
Basic Information
Top
Pathway ID | Pathway Name |
---|
| mRNA Processing |
| Gene Expression |
Pathway ID | Pathway Name |
---|
500866 | mRNA Splicing - Major Pathway |
500655 | Processing of Capped Intron-Containing Pre-mRNA |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C109238 |
acyline |
acyline results in increased expression of HNRNPR mRNA | increases expression | 17510436
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of HNRNPR mRNA | affects expression | 16483693
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of HNRNPR protein | decreases expression | 20097212
|
C055494 |
caffeic acid phenethyl ester |
[Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of HNRNPR mRNA | affects cotreatment|decreases expression | 20360939
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of HNRNPR mRNA | affects cotreatment|decreases expression | 20360939
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
4.10 | 18287403 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
2.05 | 20127859 20464547 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
7.25 | 6695378 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
7.25 | 6695378 10737359 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
4.44 | 18056438 19052882 16434500 19061943 17162532 17620307 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.56 | 19183758 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.05 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
2.05 | 17474063 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
1.87 | 17978847 16830150 17138121 21159647 16288022 19383236 18506893 18494052 17761372 16698587 17173139 20084675 19171122 20101231 3084413 16807293 16878318 3581430 20214788 18665156 16935385 19335982 20514400 16779866 16569478 20935162 19052882 18056438 20727157 17162532 19701751 17428255 18393292 11831363 19539802 19519916 18210153 19418558 16502159 20524982 16328049 19822196 18788625 19107877 19919837 16681979 17055752 18971187 19208518 18978308 20432363 19394651 18785209 20007298 20512989 18691550 10737359 10672840 16540662 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
2.13 | 20419170 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
3.09 | 17174075 7505956 21159647 2727394 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
4.01 | 19052882 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
2.25 | 20387270 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
2.13 | 19107877 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
5.73 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
2.07 | 16530937 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
3.56 | 21071580 20387270 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
2.82 | 20471113 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
2.53 | 18785209 |
MESH:D007414 |
Intestinal Neoplasms |
|
caffeic acid phenethyl ester |
4.93 | 10783313 |
MESH:D007674 |
Kidney Diseases |
|
caffeic acid phenethyl ester |
3.73 | 15369732 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
caffeic acid phenethyl ester |
4.21 | 16766008 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
2.99 | 18665156 19638242 18522880 18407596 20032147 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
2.16 | 17034775 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
4.89 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
4.89 | 12112319 19833225 12771043 16942905 21278145 19642983 20452335 20405173 19812893 15885732 19638242 19255062 20137499 19073162 19499222 20434301 19254457 10737359 19294768 19090486 18754104 18978307 18977376 2422723 19426721 19850985 20101389 20118626 18648771 19996281 19690152 20583210 18644402 2862719 15175105 20492335 20501860 21047994 21167192 9163691 19427195 19256749 21071580 19551842 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
2.83 | 19539802 9362446 16267830 16842330 19009564 18253720 18775883 19004024 18079962 19126423 18544905 18093689 19519916 3124819 17854601 17174075 2563599 21159647 18282651 18308698 18164116 17942915 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
2.46 | 20869020 18569708 17053015 18816296 20135361 20464547 20064080 6695378 18520028 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
2.46 | 20970405 21163286 20512841 6695378 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.46 | 16381670 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
2.68 | 9029167 3581430 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
2.31 | 11141357 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
3.65 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
5.73 | 20387270 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
2.52 | 16540662 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
3.88 | 2563599 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.91 | 17292933 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
2.51 | 19755658 10029692 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
2.40 | 2093021 20155912 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
2.40 | 18456281 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
3.25 | 7505956 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
2.29 | 17053015 |